Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About L. Todd Edwards

Arcutis Biotherapeutics, Inc. reported in an 8-K filed September 27, 2023 that L. Todd Edwards was appointed Chief Commercial Officer, effective September 27, 2023. The proxy statement of Arcutis Biotherapeutics, Inc. reports total compensation of $3,030,337 for L. Todd Edwards in fiscal 2025, including a base salary of $535,000. Disclosed compensation is on record for 3 fiscal years.

“On September 27, 2023, Arcutis Biotherapeutics, Inc. (the "Company" or "Arcutis") announced the appointment of L. Todd Edwards as the Company's Chief Commercial Officer, effective as of September 27, 2023.”
Arcutis Biotherapeutics, Inc. Form 8-K, filed September 27, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Arcutis Biotherapeutics, Inc.

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Arcutis Biotherapeutics, Inc. (ARQT) $535,000 $3,030,337
2024 Arcutis Biotherapeutics, Inc. (ARQT) $516,419 $1,965,145
2023 Arcutis Biotherapeutics, Inc. (ARQT) $131,254 $1,657,847

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.